Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Vaccine|August 21, 2010
Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strainsVernon J Lee, Joshua K Tay, Mark I C Chen, et al.
Gut|July 8, 2015
Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infectionChoong Tat Keng, Ching Wooen Sze, Dahai Zheng, et al.
Emerging Microbes & Infections|January 8, 2020
Longitudinal analysis of the antibody repertoire of a Zika virus-infected patient revealed dynamic changes in antibody responseXuefeng Niu, Qihong Yan, Zhipeng Yao, et al.
Nature|July 16, 2020
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNina Le Bert, Anthony T Tan, Kamini Kunasegaran, et al.
EMBO Molecular Medicine|May 31, 2020
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patientsJustin Stebbing, Venkatesh Krishnan, Stephanie de Bono, et al.
Hlife|July 12, 2024
Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individualsChee Wah Tan, Feng Zhu, Wan Ni Chia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2024
Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in miceNicholas You Zhi Cheang, Kai Sen Tan, Peck Szee Tan, et al.
NPJ Digital Medicine|June 30, 2022
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimensAgata Blasiak, Anh T L Truong, Alexandria Remus, et al.
The Journal of Experimental Medicine|March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infectionNina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
Science Advances|November 14, 2020
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityJustin Stebbing, Ginés Sánchez Nievas, Marco Falcone, et al.
Pageof 12